Investors might be interested in how sell-side analysts are viewing shares of WAVE Life Sciences Ltd. (NASDAQ:WVE). Taking a peek at the current consensus rating, we can see that the ABR is 1.67. This average rating is provided by Zacks Research. This simplified scale ranges from one to five which translates brokerage firm Buy/Sell/Hold recommendations into an average broker rating. A low number in the 1-2 range typically indicates a Buy, 3 represents a Hold and 4-5 indicates a consensus Sell rating. In terms of the number of analysts that have the stock pegged as a Buy or Strong Buy, we note that the number is presently 4.

Investors may be diving into the latest company earnings reports trying to scope out some quality stocks to add to the portfolio. Nobody knows for sure which way overall market momentum will sway as we near the close of the calendar year. Investors may be getting ready to do a portfolio review to see which stocks are worthy to hold, and which ones have underperformed a may need to be unloaded. Regularly monitoring stock investments may keep the investor ready for any big market changes that may occur.

Shifting gears, we can see that the current quarter EPS consensus estimate for WAVE Life Sciences Ltd. (NASDAQ:WVE) is -1.39. This EPS estimate is using 6 sell-side analysts polled by Zacks Research. For the prior reporting period, the company posted a quarterly EPS of -1.22. As we move through earnings season, all eyes will be on the company to see if they can beat analyst estimates and show improvement from the last quarter. When a company reports actual earnings numbers, the surprise factor can cause a stock price to realize increased activity. Investors and analysts will be closely watching to see how the earnings results impact the stock after the next release. Many investors will decide to be cautious around earnings releases and delay buy/sell moves until after the stock price has steadied.

Viewing some popular support and resistance marks on shares of WAVE Life Sciences Ltd. (NASDAQ:WVE), we can see that the 52-week high is presently $55.2, and the 52-week low is currently $19.17. When the stock is trading near the 52-week high or 52-week low, investors may be on the lookout for a potential break through the level. Looking at recent action, we can see that the stock has been trading near the $20.95 level. Investors may also want to track historical price activity. Over the past 12 weeks, the stock has changed -23.62%. Looking further back to the beginning of the calendar year, we note that shares have moved -50.17%. Over the previous 4 weeks, shares have seen a change of -0.24%. Over the last 5 trading sessions, the stock has moved -8.91%. Investors will be monitoring stock activity over the next few days to try and gauge which way the momentum is shifting.

Wall Street analysts tracking shares of WAVE Life Sciences Ltd. (NASDAQ:WVE) have been closely monitor company activities and fundamentals. They often create research reports to assist with investment decisions. On a consensus basis, analysts have set a target price of $39.4 on the stock. This number may be different from the First Call consensus target estimate. Analysts that routinely cover the company may use different techniques in order to create a future target price. Because of the different methods, price targets may differ greatly from one analyst to another.  

Active traders are often looking for the next great move to secure profits in the stock market. Traders might be tracking stocks that are primed for a breakout. When a stock suddenly breaks to the upside, it has the potential to bring the optimistic crowd along with it. The breakout may bring in traders who missed out on the beginning of a run trying to capitalize on the back end. The professional trader is typically one who is able to stand out from the crowd. Being able to separate fantasy from reality can mean big profits for the dedicated trader. Impulse buying or selling on good or bad news is common in the stock market. Being able to come to a reasonable conclusion about why stock prices are headed one way and not the other can be a tough proposition. Paying attention to all the headlines may lead some traders down the path of no return if trades are being made strictly on daily news or even perception or that news. Discerning between what is actually driving a stock and what is perceived to be driving a stock may end up being a large factor between future gains and losses in the equity market.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.